CD44 and prostate carcinoma: One hundred forty-eight prostate tissues composed of prostate cancer (PCa), high-grade prostatic intraepithelial neoplasia (HGPIN), and benign prostate hyperplasia (BPH) were immunostained for CD44 and CD133.